There are 2867 resources available
508P - High prevalence of clonal hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
Presenter: Julieta Rodriguez
Session: Poster session 13
509P - COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
Presenter: Olivier Molinier
Session: Poster session 13
510P - Long-term outcomes of COVID-19 infection in patients with solid tumors before vaccination
Presenter: Ozan Yazici
Session: Poster session 13
511P - HIV impact in localized anal carcinoma: A matched cohort study
Presenter: Amanda Acioli de Almeida
Session: Poster session 13
514P - Nerve sparing retroperitoneal lymph node dissection for clinical stage IIA/B seminomas: A clinical phase II trial
Presenter: Axel Heidenreich
Session: Poster session 13
516P - Early relapse in seminoma is associated with reduced overall survival
Presenter: Pia Paffenholz
Session: Poster session 13
709P - Real-world systemic treatment patterns of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC)
Presenter: Amit Singal
Session: Poster session 13
710P - Neoadjuvant tislelizumab for resectable recurrent hepatocellular carcinoma: A non-randomized control, phase II trial (TALENT)
Presenter: Shuling Chen
Session: Poster session 13
711P - Sintilimab combined with bevacizumab biosimilar as a conversion therapy in potentially resectable intermediate stage hepatocellular carcinoma (HCC): A phase II trial
Presenter: Huichuan Sun
Session: Poster session 13